NCT03732963View on ClinicalTrials.gov

Oral Melatonin as Premedication During MAC for Patients Undergoing Loco-regional Chronic Subdural Hematoma Evacuation

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

November 5, 2018

Study Completion Date

November 7, 2018

Conditions
Monitored Anaesthesia CareLoco-regional Chronic Subdural Hematoma Evacuation
Interventions
DRUG

Placebo (Group P)

Group P: 20 patients will receive a placebo tablet preoperatively.

DRUG

Melatonin (Group M)

Group M: 20 patients will receive an oral melatonin tablet 10 mg preoperatively.

Trial Locations (1)

11451

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03732963 - Oral Melatonin as Premedication During MAC for Patients Undergoing Loco-regional Chronic Subdural Hematoma Evacuation | Biotech Hunter | Biotech Hunter